TheProfitWatch

ATXS - Astria Therapeutics, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
12.39 0.1 (0.85%) 0.0 (0.0%) -0.01 (-0.04%) -0.03 (-0.24%) 0.09 (0.73%) 0.06 (0.52%) --- 0.09 (0.73%)

Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema. Their second product candidate is STAR-0310, a monoclonal antibody OX40 antagonist that is in preclinical development for the treatment of atopic dermatitis, or AD, an immune disorder associated with loss of skin barrier function and itching.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Market

Earnings & Ratios

Basic EPS:
-0.57
Diluted EPS:
-0.57
Basic P/E:
-21.9211
Diluted P/E:
-21.9211
RSI(14) 1m:
53.85
VWAP:
12.5
RVol:

Events

Period Kind Movement Occurred At

Related News